iBio Inc. (AMEX:IBIO) saw a downside of -7.19% to close Friday at $0.40 after subtracting -$0.03 on the day. The 5-day average trading volume is 661,280 shares of the company’s common stock. It has gained $0.4750 in the past week and touched a new high 1 time within the past 5 days. An average of 791,280 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 734,692.
IBIO’s 1-month performance is -28.32% or -$0.1700 on its low of $0.3922 reached on 08/18/23. The company’s shares have touched a 52-week low of $0.36 and high of $16.51, with the stock’s rally to the 52-week high happening on 03/21/23. YTD, IBIO has lost -9.99% or -$0.0444 and has reached a new high 12 times. However, the current price is down -97.58% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
IBIO stock investors last saw insider trading activity on Jul 27.Brenner Martin () most recently sold 4,515 shares at $0.51 per share on Jul 27. This transaction cost the insider $2,308., Brenner Martin, sold 47,020 shares at a price of $0.59 on Jul 12. Then, on Jun 21, Brenner Martin sold 4,184 shares at a price of $0.68 per share. This transaction amounted to $2,849.
Valuation Metrics
IBIO stock has a beta of -3.12. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 19.44 while the price-to-book (PB) in the most recent quarter is 0.30.
The trailing 12-month EBITDA margin is -1951.24%. The firm’s gross profit as reported stood at $2.17 million against revenue of $2.38 million.
Earnings Surprise
Net income shrunk -63.79% to -$7.29 million, while revenue of -$33.55 million was -360.22% off the previous quarter. EBITDA for the quarter stood at more than -$5.84 million. IBIO stock balance sheet for the recent quarter shows that total liabilities totaled 27.0 million, with total debt at $18.43 million. Shareholders hold equity totaling $16.8 million.
Let’s look briefly at iBio Inc. (IBIO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 33.08% to suggest the stock is trending Neutral, with historical volatility in this time period at 64.80%.
The stock’s 5-day moving average is $0.4222, reflecting a -9.93% or -$0.0441 change from its current price. IBIO is currently trading -27.27% above its 20-day SMA, -83.54% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -48.59% and SMA200 by-81.74%.
Stochastic %K and %D was 4.04% and 4.49% and the average true range (ATR) pointed at 0.0544. The RSI (14) points at 34.37%, while the 14-day stochastic is at 1.92% with the period’s ATR at 0.0539. The stock’s 9-day MACD Oscillator is pointing at -0.0312 and -0.0686 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for iBio Inc. (AMEX: IBIO), JMP Securities launched coverage with a Mkt outperform rating. Analysts offering their rating for IBIO stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate IBIO as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 0 have offered a “buy” rating.
What is IBIO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $1.00 and a high of $1.00, with their median price target at $1.00. Looking at these predictions, the average price target given by analysts is for iBio Inc. (IBIO) stock is $1.00.
